Expression of tumor suppressor gene ING4 in ovarian carcinoma is correlated with microvessel density.
作者： Yinglan Liu , Liqian Yu , Yingwei Wang , Yaling Zhang , Yingchao Wang
DOI: 10.1007/S00432-011-1099-5
关键词:
摘要: Purpose Angiogenesis, estimated by microvessel density (MVD), has been shown to predict poor progression-free survival in women with advanced epithelial ovarian cancer. Inhibitor of growth (ING) family proteins inhibit angiogenesis a number cancers. We evaluated the role ING4 regulation patients
springer.com
sci-hub.se 参考文章(42)
Natacha Heutte, Alexandre Labiche, Paulette Herlin, Pascal Gauduchon, Michel Henry-Amar, Florence Joly, Nicolas Elie, Jean-Francois Heron, Yves Denoux, Hubert Crouet, Prognostic significance of tumour vascularisation on survival of patients with advanced ovarian carcinoma Histology and Histopathology. ,vol. 24, pp. 425- 435 ,(2009) , 10.14670/HH-24.425
Qiu-shi Wang, Ming Li, Lin-you Zhang, Yan Jin, Dan-dan Tong, Yang Yu, Jing Bai, Qi Huang, Fang-Li Liu, An Liu, Ki-Young Lee, Song-bin Fu, Down-regulation of ING4 is associated with initiation and progression of lung cancer. Histopathology. ,vol. 57, pp. 271- 281 ,(2010) , 10.1111/J.1365-2559.2010.03623.X
Ettore Appella, Mariko Kitahama-Shiseki, Remy M. Pedeux, Masayuki Shiseki, Curtis C. Harris, Makoto Nagashima, Jun Yokota, Koh Miura, Yuichiro Higashimoto, Hitoshi Onogi, Shu Okamura, p29ING4 and p28ING5 bind to p53 and p300, and enhance p53 activity. Cancer Research. ,vol. 63, pp. 2373- 2378 ,(2003)
Patricia Pautier, Florence Joly, Pierre Kerbrat, Philippe Bougnoux, Pierre Fumoleau, Thierry Petit, Olivier Rixe, François Ringeisen, Annie Tisseron Carrasco, Catherine Lhommé, Phase II study of gefitinib in combination with paclitaxel (P) and carboplatin (C) as second-line therapy for ovarian, tubal or peritoneal adenocarcinoma (1839IL/0074) ☆ Gynecologic Oncology. ,vol. 116, pp. 157- 162 ,(2010) , 10.1016/J.YGYNO.2009.10.076
Abdullah Ozer, Richard K. Bruick, Regulation of HIF by prolyl hydroxylases: recruitment of the candidate tumor suppressor protein ING4. Cell Cycle. ,vol. 4, pp. 1153- 1156 ,(2005) , 10.4161/CC.4.9.2040
Xin Zhang, Ke-Sheng Wang, Zhi-Qin Wang, Lu-Sheng Xu, Qing-Wan Wang, Fei Chen, Dong-Zhi Wei, Ze-Guang Han, Nuclear localization signal of ING4 plays a key role in its binding to p53 Biochemical and Biophysical Research Communications. ,vol. 331, pp. 1032- 1038 ,(2005) , 10.1016/J.BBRC.2005.04.023
Louis M. Sherwood, Edith E. Parris, Judah Folkman, Tumor Angiogenesis: Therapeutic Implications New England Journal of Medicine. ,vol. 285, pp. 1182- 1186 ,(1971) , 10.1056/NEJM197111182852108
Douglas Hanahan, Judah Folkman, Patterns and Emerging Mechanisms of the Angiogenic Switch during Tumorigenesis Cell. ,vol. 86, pp. 353- 364 ,(1996) , 10.1016/S0092-8674(00)80108-7
Michael J. Goodheart, Justine M. Ritchie, Stephen L. Rose, John P. Fruehauf, Barry R. De Young, Richard E. Buller, The Relationship of Molecular Markers of p53 Function and Angiogenesis to Prognosis of Stage I Epithelial Ovarian Cancer Clinical Cancer Research. ,vol. 11, pp. 3733- 3742 ,(2005) , 10.1158/1078-0432.CCR-04-0056
A. Ozer, L. C. Wu, R. K. Bruick, The candidate tumor suppressor ING4 represses activation of the hypoxia inducible factor (HIF) Proceedings of the National Academy of Sciences of the United States of America. ,vol. 102, pp. 7481- 7486 ,(2005) , 10.1073/PNAS.0502716102